Skip to main content
. 2017 Mar 10;7:44210. doi: 10.1038/srep44210

Figure 1.

Figure 1

(A) Chemical structures and synthetic route for the GA–GFFYK(Cur)E-ss-ERGD (i: glutaricacid anhydride, pyridine, ii: N-hydroxy succinimide (NHS), dicyclohexylcarbodiimide (DCC), DMF, iii: DMF, DIPEA), (B) diagram to illustrate the mechanism of our compounds for tumor targeting therapy.